Skip to content
10-Q

Quarterly Report

Passage BIO, Inc. PASG

0001104659-25-109180

← back to feed
Filed
Nov 10, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 6, 2025 3.18M sh
Shares Diluted Q3 2025 · Sep 30, 2025 3.18M sh
Shares Diluted Q3 2025 · Sep 30, 2025 3.17M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 3.15M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 3.05M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$25.03M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$39.51M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $52.77M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $37.57M
Stockholders Equity Q3 2025 · Sep 30, 2025 $31.12M
Stockholders Equity Q3 2025 · Jun 30, 2025 $38.26M
Stockholders Equity Q3 2025 · Dec 31, 2024 $61.26M
Stockholders Equity Q3 2025 · Sep 30, 2024 $72.72M
Stockholders Equity Q3 2025 · Jun 30, 2024 $90.56M
Stockholders Equity Q3 2025 · Dec 31, 2023 $111.28M
Current Liabilities Q3 2025 · Sep 30, 2025 $22.25M
Current Liabilities Q3 2025 · Dec 31, 2024 $19.36M
Total Liabilities Q3 2025 · Sep 30, 2025 $43.04M
Total Liabilities Q3 2025 · Dec 31, 2024 $41.15M
Current Assets Q3 2025 · Sep 30, 2025 $55.73M
Current Assets Q3 2025 · Dec 31, 2024 $78.82M
Total Assets Q3 2025 · Sep 30, 2025 $74.16M
Total Assets Q3 2025 · Dec 31, 2024 $102.41M
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.44
Eps Diluted Q3 2025 · Sep 30, 2025 −$10.26
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$6.15
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$17.04
Eps Basic Q3 2025 · Sep 30, 2025 −$2.44
Eps Basic Q3 2025 · Sep 30, 2025 −$10.26
Eps Basic restated Q3 2025 · Sep 30, 2024 −$6.15
Eps Basic restated Q3 2025 · Sep 30, 2024 −$17.04
Sga Expense Q3 2025 · Sep 30, 2025 $4.35M
Sga Expense Q3 2025 · Sep 30, 2025 $14.95M
Sga Expense Q3 2025 · Sep 30, 2024 $7.25M
Sga Expense Q3 2025 · Sep 30, 2024 $20.28M
Rd Expense Q3 2025 · Sep 30, 2025 $4.31M
Rd Expense Q3 2025 · Sep 30, 2025 $17.86M
Rd Expense Q3 2025 · Sep 30, 2024 $8.66M
Rd Expense Q3 2025 · Sep 30, 2024 $30.62M
Net Income Q3 2025 · Sep 30, 2025 −$7.75M
Net Income Q3 2025 · Sep 30, 2025 −$32.54M
Net Income Q3 2025 · Sep 30, 2024 −$19.34M
Net Income Q3 2025 · Sep 30, 2024 −$52.04M
Operating Income Q3 2025 · Sep 30, 2025 −$8.66M
Operating Income Q3 2025 · Sep 30, 2025 −$35.45M
Operating Income Q3 2025 · Sep 30, 2024 −$20.7M
Operating Income Q3 2025 · Sep 30, 2024 −$56.13M